In a BSE filing, Glenmark said it "has been granted tentative approval by the US Food & Drug Administration (USFDA) for its Dronedarone Tablets, 400 mg, the generic version of Multaq Tablet, 400 mg of Sanofi-Aventis US LLC."
The government is likely to commission a study soon to assess the impact of foreign direct investment in existing pharmaceutical companies in view of concerns expressed on the issue by a Parliamentary panel.
Genzyme, a fully-owned subsidiary of drug major Sanofi-Aventis, alleged that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts.
In its petition filed in the District Court of Delaware, Genzyme alleged that DRL intimated though a letter that it had submitted an Abbreviated New Drug Application with US FDA seeking approval to engage in the commercial manufacture, importation, use, and sale of 20 mg/ml Plerixafor injection as a generic version of Mobozil drug.
The stock hit 5 percent upper circuit limit on Wednesday following a report that companies like Sanofi Aventis, Novartis and GlaxoSmithKline were in the race to buy out the company's domestic formulations business.
The report states that Sanofi and GSK have put in non-binding bids and Novartis has signed a non-disclosure agreement to acquire the domestic formulations business of Elder Pharma.
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
Pharma major Lupin today said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration to market a generic version of Sanofi Aventis's Avapro tablets.
Karvy Stock Broking has come out with its report on pharma pricing policy. The research firm initial assessment is based on a 50 % price cut and a possible 80% price cut for products marked in Light Blue. The impact based on the above methodology shows a higher impact on Sanofi Aventis, GSK Pharma, Cipla, Ranbaxy Labs.
Wockhardt shares hit a 52-week high of Rs 1,275.50 on NSE on Thursday after the drug maker said it has received final US Food and Drugs Administration (FDA) approval to market Clopidogrel bi-sulfate tablets, used to help reduce risk of heart attack or stroke, in in 75 mg strength.
Dr Reddy's Laboratories and Aurobindo Pharma have received US Food and Drugs Administration (FDA) approval to sell a generic version of Clopidogrel tablets, the two companies said on Friday.
Sanofi Aventis told CNBC-TV18 that it has asked the French government to intercede with the Indian tax department to waive the tax on its acquisition of Shanta Biotech
The world of pediatric vaccines is about to be shaken. And it's Hyderabad based Shantha Biotech that's going to do all the shaking
The past few years has seen several multi national pharmaceutical companies come to India looking to make acquisitions. One such company is Sanofi-Aventis who's chief executive officer Chris Viehbacher believes 'India is one of the most exciting countries in the world at this stage.'
Over the last few months, India has been playing host to the chiefs of the biggest pharma giants in the world, reports CNBC-TV18’s Archana Shukla.
The World Health Organization (WHO) troubles for Shantha Biotech, the Indian vaccine unit of Sanofi Aventis seem to be on their way out.
A US District Court has ordered the seizure of a drug made by Cipla and sold by Velecra. S Radhakrishnan, CFO, Cipla has clarified on CNBC-TV18 that they are in process of filing an appeal within the next 60 days.
Sanofi Aventis recently announced that a US Court has ordered the seizure of Frontline Plus, a drug produced by Cipla and sold by Velecra. On the back of this, the share price of Cipla has fallen around 1.5%.
A subsidiary of Sun Pharmaceutical Industries has received approval from the US Foods and Drugs Administration for its new drug application for anti-cancer Docefrez (Docetaxel) injection.
Growing generic competition knocked first quarter earnings at Sanofi-Aventis, underscoring the French drugmaker's need to integrate its recent purchase of US biotech Genzyme to counter the threat.
India's No 2 drugmaker Dr. Reddy's Laboratories said on Thursday it has launched its over-the-counter Fexofenadine HCl tablets, a generic version of Sanofi Aventis' antihistamine drug Allegra.
Having won a legal tussle, Dr Reddy's Laboratories on Thursday finally launched its generic Allegra tablets, Fexofenadine HCl, in the US market. DRL will market the over-the-counter product under store brand labels in the US market.
A global deal is tantalisingly close under which countries would share flu virus samples in exchange for access to affordable vaccines derived from them, thus saving lives in a pandemic, senior diplomats said.
French drugmaker Sanofi-Aventis said it had gained control of Genzyme, with trading in certificates used to help win over shareholders in the US biotech set to start trading later on Monday.
It took the rarefied air of the Swiss Alps to bring together the chief executives of Sanofi-Aventis and Genzyme Corp and pave the way for a USD 20.1 billion deal.